PART 4 | REQUIREMENTS RELATING TO PATIENT CARE |
| Additional function and duty of quality assurance committee |
11. In addition to the functions and duties under regulation 21(2) of the General Regulations, every quality assurance committee appointed by a licensee must review each occurrence of a patient contracting a specified infectious disease in the course of receiving an outpatient renal dialysis service from the licensee, to —| (a) | identify the cause of the occurrence; and | | (b) | recommend to the licensee new policies or procedures, or changes to policies or procedures, to minimise any such future occurrence. |
|
| General requirements relating to provision of patient care |
12.—(1) A licensee must ensure that every patient is properly assessed and the appropriate care and treatment is provided to the patient in a proper, effective and safe manner.| (2) A licensee must ensure that no personnel provides a service or does an act beyond his or her professional expertise and qualifications. |
|
13.—(1) A licensee must ensure that there is an adequate number of nursing personnel —| (a) | present at each approved permanent premises during the period when any outpatient renal dialysis service is provided at the approved permanent premises; | | (b) | available at all times to be present in person at any temporary premises to provide nursing care to any patient receiving haemodialysis at the temporary premises; and | | (c) | who have the appropriate qualifications, experience and competency to ensure that timely and appropriate nursing care is provided to the licensee’s patients. |
| (2) Without limiting paragraph (1), the licensee must allocate the appropriate nursing personnel commensurate to the number and type of patients expected at each premises at which the licensee provides an outpatient renal dialysis service, to ensure the safe provision of the outpatient renal dialysis service. |
|
| Patients must be monitored when undergoing haemodialysis |
14.—(1) A licensee must ensure that every patient undergoing haemodialysis at any approved permanent premises is monitored by a nursing personnel or a medical practitioner so that the patient can receive the appropriate and timely medical care in the event the patient’s condition deteriorates.(2) Without limiting paragraph (1), a licensee must —| (a) | implement protocols for the recognition of any deterioration in a patient’s condition, provision of medical care and escalation for further medical care; | | (b) | ensure that every medical practitioner, registered nurse and enrolled nurse employed or engaged by the licensee for the provision of the outpatient renal dialysis service is familiar with the signs and symptoms of patient deterioration and is able to identify these signs and symptoms; | | (c) | ensure that any deterioration in a patient’s condition is brought to the attention of the appropriate personnel in a timely manner; and | | (d) | ensure that all dialysis machines are equipped with the appropriate equipment or device —| (i) | to enable the licensee’s personnel to visually monitor the clinical and dialysis parameters of a patient undergoing haemodialysis; and | | (ii) | that will give an audiovisual alarm if there is any machine fault detected, or if the patient’s clinical or dialysis parameters fall outside of the acceptable range during haemodialysis. |
|
|
|
| Essential life‑saving measures must be available |
15.—(1) A licensee must —| (a) | ensure that adequate and appropriate facilities, equipment and drugs for the provision of any essential life‑saving measure to a patient are readily available at every premises where the outpatient renal dialysis service is provided; and | | (b) | at all times, be capable of providing any essential life‑saving measures to any patient who is at risk of death. |
(2) Without limiting paragraph (1), a licensee must ensure the following:| (a) | only resuscitation drugs that have not passed their expiry dates and are fit for use and resuscitation equipment that is fit for use are made available for use in the provision of any essential life‑saving measure; | | (b) | the establishment and implementation of protocols for —| (i) | the rapid and accurate assessment of any patient who presents symptoms of being or feeling unwell; | | (ii) | any medical emergency related to the conduct of haemodialysis; and | | (iii) | any medical emergency related to the conduct of peritoneal dialysis by the patient or by the licensee where it is provided as part of peritoneal dialysis support; |
| | (c) | every personnel who provides any essential life‑saving measure to a patient is adequately trained —| (i) | to provide the essential life‑saving measure in a proper, effective and safe manner; and | | (ii) | in the use of the equipment that is needed to deliver the essential life‑saving measure; |
| | (d) | the safe and timely conveyance of a patient to the care of an acute hospital licensee if the licensee’s personnel are unable to stabilise the patient’s condition. |
|
| (3) A licensee must ensure that each protocol mentioned in paragraph (2)(b) is documented and that all personnel are trained and proficient in implementing the protocol. |
|
| Drugs used for outpatient renal dialysis service |
16. A licensee must ensure that —| (a) | there is an adequate supply of the appropriate drugs at any premises where the outpatient renal dialysis service is provided, to safely and effectively conduct haemodialysis or provide peritoneal dialysis support; and | | (b) | a drug is not used for the outpatient renal dialysis service —| (i) | after its expiry date; or | | (ii) | if there is any other reason for any personnel to suspect that the drug is no longer suitable to be used for the outpatient renal dialysis service. |
|
|
| Requirements for provision at temporary premises |
17.—(1) A licensee who is approved to provide an outpatient renal dialysis service using temporary premises must —| (a) | ensure that in determining whether the outpatient renal dialysis service may be provided to a patient at any temporary premises in a proper, effective and safe manner, the licensee must take into account —| (i) | the patient’s medical condition or history; and | | (ii) | the facilities, equipment, medical supplies and other resources that are available at the temporary premises; |
| | (b) | establish, implement and regularly review guidelines to assist the licensee in making the determination mentioned in sub‑paragraph (a); | | (c) | where the licensee provides haemodialysis at temporary premises — ensure that the personnel deployed to provide haemodialysis is a registered nurse or medical practitioner, who has the necessary experience, competency and skills to provide haemodialysis safely without supervision; and | | (d) | where the licensee provides peritoneal dialysis support at temporary premises — ensure that the personnel deployed to provide peritoneal dialysis support is an enrolled nurse, a registered nurse or a medical practitioner, who has the necessary experience, competency and skills to provide peritoneal dialysis support safely without supervision. |
| (2) A licensee must ensure that every personnel who attends to a patient at any temporary premises carries proof of the personnel’s identity and his or her role or designation for which the personnel is engaged or employed by the licensee, and shows the proof to the patient. |
|
| Requirements for remote provision |
18.—(1) This regulation applies to a licensee who is approved to provide an outpatient renal dialysis service by remote provision.(2) Before a licensee provides any outpatient renal dialysis service to a patient by remote provision, the licensee must ensure that —| (a) | the licensee’s personnel who is a healthcare professional first conducts a clinical assessment of the patient in person at any of the licensee’s approved permanent premises or temporary premises; or | | (b) | where it is not practicable for the patient to be clinically assessed in person before the outpatient renal dialysis service is provided remotely — the patient is given an appointment to be clinically assessed in person at any of the licensee’s approved permanent premises or temporary premises by a healthcare professional who is the licensee’s personnel. |
|
|
| Conduct of ultrasound imaging |
19.—(1) A licensee must not conduct any ultrasound imaging on a patient unless a medical practitioner or collaborative prescribing practitioner who is the licensee’s personnel orders the ultrasound imaging for the patient.(2) A licensee must ensure that any ultrasound imaging conducted on a patient is conducted —| (a) | only as a service incidental to the provision of an outpatient renal dialysis service; | | (b) | at the licensee’s approved permanent premises or temporary premises, as the case may be; and | | (c) | by the licensee’s personnel who is —| (i) | a medical practitioner who is trained in the conduct of ultrasound imaging; | | (ii) | a radiographer who is a duly qualified allied health professional; | | (iii) | a sonographer; or | | (iv) | where ultrasound imaging is conducted only for the purpose of arteriovenous cannulation — a registered nurse or an enrolled nurse who is trained in conducting ultrasound imaging for the purpose of arteriovenous cannulation. |
|
|
|
20.—(1) Subject to paragraph (2), a licensee must not test any specimen for a patient unless —| (a) | a medical practitioner or collaborative prescribing practitioner who is the licensee’s personnel orders the test for the patient; | | (b) | the testing of the specimen only involves the conduct of a simple in vitro diagnostic test; and | | (c) | the testing of the specimen is provided only as a service incidental to the provision of an outpatient renal dialysis service. |
| (2) A licensee who is approved to provide an outpatient renal dialysis service by remote provision must not, in the course of providing the service by that service delivery mode, direct a patient to conduct a self‑administered test on himself or herself if the testing material for the self‑administered test is a “professional use only” medical device within the meaning given by regulation 2 of the Health Products (Medical Devices) Regulations 2010 (G.N. No. S 436/2010). |
|
| Conduct of simple in vitro diagnostic test |
21.—(1) A licensee must ensure that any simple in vitro diagnostic test on a specimen or patient must be conducted —| (a) | using testing material in respect of which —| (i) | the expiry date has not passed; and | | (ii) | the personnel who is administering the test does not suspect or have any reason to suspect that the testing material is no longer fit for use; and |
| | (b) | in accordance with the instructions specified by the manufacturer of the testing material. |
| (2) A licensee must ensure that any testing material that may be used to conduct any simple in vitro diagnostic testing is stored under the conditions, and handled in the manner, specified by the manufacturer of the testing material so as to lower the risk of contamination, unnecessary exposure of the testing material to the environment and early deterioration of the testing material. |
|
| Instructions for self‑collection of specimens |
22. Where any specimen is to be collected from a patient by the patient himself or herself, for the purpose of conducting any test on it (whether or not the test is to be self‑administered by the patient), a licensee must provide the patient with —| (a) | instructions on how and when the specimen is to be collected; and | | (b) | the precautions that are to be taken to avoid contamination and degradation of the specimen. |
|
|